Bupropion Hydrochloride

Product NDC
50090-7113
11-digit product format
500907113
Labeler code
50090
Product ID
50090-7113_85ec5376-b7ef-4a0b-aa86-6918c483c520
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
bupropion hydrochloride
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Labeler
A-S Medication Solutions
Application
ANDA210015
Marketing category
ANDA
Marketing start
2023-04-30
Substance
BUPROPION HYDROCHLORIDE
Active strength
150 mg/1
Pharmacologic classes
Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Related Records

Related UNII Ingredients

UNIIPreferred termRegistry numberMatched term
ZG7E5POY8OBUPROPION HYDROCHLORIDE31677-93-7BUPROPION HYDROCHLORIDE

Packages

Package NDC11-digit formatDescriptionMarketing startSampleExclude flagStatus
50090-7113-05009071130090 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-7113-0) 2024-03-11NoNoHistorical
50090-7113-15009071130130 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-7113-1) 2024-03-11NoNoHistorical
50090-7113-25009071130260 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-7113-2) 2024-03-11NoNoHistorical

Related DailyMed Labels

TitleManufacturerEffective dateTypeVersion
Bupropion Hydrochloride XLA-S Medication Solutions2024-03-13HUMAN PRESCRIPTION DRUG LABEL2